Search

Karyopharm Therapeutics Inc

Gesloten

SectorGezondheidszorg

1.69 1.2

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.65

Max

1.83

Belangrijke statistieken

By Trading Economics

Inkomsten

-45M

-67M

Verkoop

-1.6M

33M

EPS

-2.32

Winstmarge

-200.476

Werknemers

228

EBITDA

-44M

-54M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+284.47% upside

Dividenden

By Acuity

Volgende Winsten

2 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-8.1M

36M

Vorige openingsprijs

0.49

Vorige sluitingsprijs

1.69

Nieuwssentiment

By Acuity

36%

64%

80 / 339 Rangschikking in Healthcare

Karyopharm Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 sep 2026, 20:07 UTC

Karyopharm Therapeutics Inc is gaining during Thursday's trading, advancing significantly since Wednesday's close and peaking near the session's end.

16 sep 2026, 19:43 UTC

Karyopharm Therapeutics Inc is trading sharply higher, reaching a peak this morning before slightly retracing, but remains below its 20-day moving average.

15 sep 2026, 19:53 UTC

Karyopharm Therapeutics Inc shares are lower amid broader market declines and investor concerns over anticipated Federal Reserve rate hikes and geopolitical tensions.

11 sep 2026, 20:01 UTC

News
Macro Event

Karyopharm Therapeutics has entered a Forbearance Agreement, trading lower as it faces a $15.8 million principal payment due and $20 million in fees.

10 sep 2026, 20:07 UTC

Karyopharm Therapeutics is lower today, continuing a broader trend of weakness and remaining below its 20-day moving average. No specific news was identified.

8 sep 2026, 20:07 UTC

News

Karyopharm Therapeutics shares are lower after downgrades from Robert W. Baird and HC Wainwright, with a target price set at $3.00.

2 sep 2026, 20:08 UTC

Karyopharm Therapeutics Inc shares are lower today, having reached a session low earlier. The stock remains near the lower end of its one-month range.

1 sep 2026, 20:01 UTC

Event

Karyopharm Therapeutics submitted a supplemental New Drug Application for XPOVIO, but shares are trading lower amid broader market concerns about rising oil prices and interest rates.

31 aug 2026, 20:02 UTC

Event
News
Social Media

Karyopharm Therapeutics submitted a supplemental New Drug Application for XPOVIO, seeking Accelerated Approval for myelofibrosis treatment. Shares are gaining during Monday's session.

28 aug 2026, 20:08 UTC

Karyopharm Therapeutics Inc shares declined during Friday's session amid rising U.S. Treasury yields, reflecting broader market trends. The stock finished near its one-month low.

25 aug 2026, 20:07 UTC

Karyopharm Therapeutics Inc shares are higher during Tuesday's session, reaching a peak earlier in the day. The stock remains below its 20-day moving average.

24 aug 2026, 19:16 UTC

Karyopharm Therapeutics Inc shares are lower today, reaching a session low amid ongoing market weakness and no specific news to explain the decline.

21 aug 2026, 23:51 UTC

Karyopharm Therapeutics Inc shares are lower in after-market hours, following a brief uptick earlier. No specific news was identified to explain the decline.

20 aug 2026, 20:02 UTC

Karyopharm Therapeutics is declining sharply amid a significant downturn in the Biotechnology sub-sector, nearing the lower end of its one-month trading range.

18 aug 2026, 20:03 UTC

Karyopharm Therapeutics Inc is trading higher today, continuing its upward trend since Monday's close. The stock remains below its 20-day moving average.

17 aug 2026, 23:46 UTC

Karyopharm Therapeutics shares are higher in after-market hours, following volatility earlier. Broader market pressures include geopolitical tensions and rising crude oil prices.

14 aug 2026, 23:51 UTC

Karyopharm Therapeutics shares are higher in after-market trading, despite no specific news. Broader market sentiment reflects concerns from a decline in U.S. retail sales.

13 aug 2026, 23:11 UTC

Karyopharm Therapeutics Inc shares are rising in after-market trading, showing a modest upward trend since Thursday's close despite recent significant declines.

12 aug 2026, 19:56 UTC

Karyopharm Therapeutics Inc shares are lower today, retracing from an early high amid broader market conditions and geopolitical tensions. No specific news was identified.

11 aug 2026, 20:01 UTC

Karyopharm Therapeutics Inc is trading higher today, having reached a peak earlier in the session. The stock remains below its 20-day moving average.

10 aug 2026, 20:06 UTC

Karyopharm Therapeutics Inc shares are lower today, reversing an early gain and reaching a mid-morning low, with no specific news identified for the decline.

7 aug 2026, 23:31 UTC

Karyopharm Therapeutics shares are lower in after-market hours, following a decline earlier despite gains in major tech stocks. No specific news was identified.

6 aug 2026, 23:21 UTC

Karyopharm Therapeutics Inc shares are lower in after-market hours. The asset is trading below its 20-day moving average and near the lower end of its one-month range.

5 aug 2026, 23:01 UTC

Karyopharm Therapeutics shares are lower in after-market hours, continuing a three-session decline amid broader market weakness from disappointing U.S. employment data.

4 aug 2026, 23:46 UTC

Karyopharm Therapeutics shares are higher in after-market trading, though no specific news explains the movement. Broader market optimism may be influencing risk assets.

3 aug 2026, 23:41 UTC

News

Karyopharm Therapeutics shares are lower in after-market hours following the grant of restricted stock units to a new employee, raising potential dilution concerns.

1 aug 2026, 00:01 UTC

Karyopharm Therapeutics Inc shares are higher in after-market hours, reaching their highest cumulative return of the day despite recent underperformance.

31 jul 2026, 23:31 UTC

Karyopharm Therapeutics shares rose during after-market hours, continuing a recovery from an earlier low. The stock remains below its 20-day moving average.

30 jul 2026, 23:41 UTC

Social Media
Event
News

Karyopharm Therapeutics shares fell sharply after its Phase 3 trial for selinexor failed to meet key endpoints, leading to a shift in focus away from endometrial cancer.

29 jul 2026, 19:27 UTC

Macro Event

Karyopharm Therapeutics shares are lower as investor anxiety rises following the Federal Reserve's decision to maintain interest rates amid global uncertainties.

Peer Vergelijking

Prijswijziging

Karyopharm Therapeutics Inc Prognose

Koersdoel

By TipRanks

284.47% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 6.536 USD  284.47%

Hoogste 11 USD

Laagste 3 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Karyopharm Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

6 ratings

4

Buy

2

Hold

0

Sell

Sentiment

By Acuity

80 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

help-icon Live chat